Development of De Novo Antibody in Renal Transplant Recipients with BK Viremia Managed with Immunosuppression Reduction

被引：0
|
作者：
Dvorai, R. Hod [1 ]
Lee, R. [2 ]
Muluhngwi, P. [2 ]
Raijmakers, M. [3 ]
Shetty, A. [2 ]
Tambur, A. [2 ]
Ison, M. [2 ]
机构：
[1] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA
[2] Northwestern Univ, Chicago, IL 60611 USA
[3] Univ Santiago, Santiago, Chile
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2020年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
D-182
引用
收藏
页码：822 / 823
页数：2
相关论文
共 50 条
  • [1] Development of De Novo Antibody in Renal Transplant Recipients with BK Viremia Managed with Immunosuppression Reduction
    Raijmakers, M.
    Shetty, A.
    Dvorai, R. Hod
    Tambur, A.
    Ison, M. G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 984 - 984
  • [2] Development of De Novo Antibody in Renal Transplant Recipients with BK Viremia Managed with Immunosuppression Reduction
    Dvorai, R. Hod
    Lee, R.
    Muluhngwi, P.
    Raijmakers, M.
    Shetty, A.
    Tambur, A.
    Ison, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 454 - 455
  • [3] Development of de novo donor-specific antibodies in renal transplant recipients with BK viremia managed with immunosuppression reduction
    Hod-Dvorai, Reut
    Lee, Ryan
    Muluhngwi, Penn
    Raijmakers, Mariella
    Shetty, Aneesha
    Tambur, Anat R.
    Ison, Michael G.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (01)
  • [4] Graft loss among renal-transplant recipients with early reduction of immunosuppression for BK viremia
    Marwan M Azar
    Roland Assi
    Aziz K Valika
    David B Banach
    Isaac E Hall
    Marie-Louise Landry
    Maricar F Malinis
    [J]. World Journal of Transplantation, 2017, 7 (05) : 269 - 275
  • [5] Incidence and Factors Associated with De Novo DSA After BK Viremia in Renal Transplant Recipients.
    Patel, S.
    Kuten, S.
    Knight, R.
    Nguyen, D.
    Graviss, E.
    Gaber, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 769 - 769
  • [6] Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in De Novo renal transplant recipients?: A prospective study
    Almeras, Cyrielle
    Foulongne, Vincent
    Garrigue, Valerie
    Szwarc, Ilan
    Vetromile, Fernando
    Segondy, Michel
    Mourad, Georges
    [J]. TRANSPLANTATION, 2008, 85 (08) : 1099 - 1104
  • [7] Kidney Transplant Recipients with De Novo Donor Specific Antibody is Associated with Increased Risk of Developing BK Viremia
    Kareem, S.
    Suresh, L.
    Gundroo, A.
    Von Viger, J.
    Chang, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 816 - 816
  • [8] EFFECTIVENESS AND SAFETY OF AN IMMUNOSUPPRESSION REDUCTION PROTOCOL FOR THE TREATMENT OF BK VIREMIA IN KIDNEY TRANSPLANT RECIPIENTS
    Hebmann, D.
    Moreau, K.
    Garrigue, I.
    Couzi, L.
    Merville, P.
    Taton, B.
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 21 - 21
  • [9] Relationship Between BK Viremia, De Novo Anti-HLA DSA, and Outcomes in Renal Transplant Recipients
    Dieplinger, G.
    Everly, M.
    Rebellato, L.
    Haisch, C.
    Briley, K.
    Bolin, P.
    Kendrick, W.
    Kendrick, S.
    Morgan, C.
    Hoermann, M.
    Maldonado, A.
    Harland, R.
    Terasaki, P.
    [J]. TRANSPLANTATION, 2014, 98 : 85 - 85
  • [10] BK Nephropathy, but Not Isolated BK Viremia Associated with De Novo DSA Despite Similar Immunosuppression Reduction.
    Cheungpasitporn, W.
    Mitema, D.
    Amer, H.
    Cosio, F.
    Stegall, M.
    Schinstock, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 357 - 357
12345